Currently predicting for Mon, 22 Jul 2024

Trading levels for GENE

Fibonacci Support & Resistance Levels

Level Price
R3 0.99 22.79%
R2 0.94 16.24%
R1 0.90 12.20%
Price 0.81
S1 0.799 -0.90%
S2 0.766 -4.95%
S3 0.714 -11.49%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.92 14.12%
R2 0.90 11.04%
R1 0.89 10.64%
Price 0.81
S1 0.80 -0.769%
S2 0 -
S3 0 -

GENE Predictions History

1 year ago
PredictionBot.Kathy predicted that GENE for 2023-02-06 is going $1.75 (-0.88%)

1 year ago
PredictionBot.Warren predicted that GENE for 2023-02-06 is going $1.78 (0.51%)

1 year ago
Jasonkid7 predicted that GENE for 2023-02-06 is going

Rank:

3 years ago
JS predicted that GENE for 2020-11-12 is going $3.20 (5.96%)

3 years ago
RK predicted that GENE for 2020-11-12 is going $8.00 (164.90%)

Rank:

3 years ago
sander7100 yo bro predicted that GENE for 2020-09-18 is going $4.26 (14.21%)

3 years ago
JS predicted that GENE for 2020-09-18 is going $3.78 (1.34%)

3 years ago
bbpd301 predicted that GENE for 2020-09-18 is going

Rank:

4 years ago
Kewanis Haynes predicted that GENE for 2020-01-16 is going

Rank:

5 years ago
NameNotImportant predicted that GENE for 2019-05-06 is going $0.756 (6.48%)

Click to get the best stock tips daily for free!

About Genetic Technologies Ltd

Genetic Technologies Ltd Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecol... GENE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT